Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat by Johansson, Hanna Katarina Lilith et al.
Vol.:(0123456789) 
Archives of Toxicology (2020) 94:1241–1250 
https://doi.org/10.1007/s00204-020-02697-3
MOLECULAR TOXICOLOGY
Calretinin is a novel candidate marker for adverse ovarian effects 
of early life exposure to mixtures of endocrine disruptors in the rat
Hanna Katarina Lilith Johansson1  · Terje Svingen1  · Julie Boberg1  · Paul A. Fowler2  · David Stead2 · 
Anne Marie Vinggaard1  · Panagiotis Filis2 
Received: 23 September 2019 / Accepted: 2 March 2020 / Published online: 27 March 2020 
© The Author(s) 2020
Abstract
Disruption of sensitive stages of ovary development during fetal and perinatal life can have severe and life-long consequences 
for a woman’s reproductive life. Exposure to endocrine disrupting chemicals may affect ovarian development, leading to 
subsequent reproductive disorders. Here, we investigated the effect of early life exposure to defined mixtures of human-
relevant endocrine disrupting chemicals on the rat ovary. We aimed to identify molecular events involved in pathogenesis 
of ovarian dysgenesis syndrome that have potential for future adverse outcome pathway development. We therefore focused 
on the ovarian proteome. Rats were exposed to a mixture of phthalates, pesticides, UV-filters, bisphenol A, butyl-paraben, 
and paracetamol during gestation and lactation. The chemicals were tested together or in subgroups of chemicals with anti-
androgenic or estrogenic potentials at doses 450-times human exposure. Paracetamol was tested separately, at a dose of 
360 mg/kg. Using shotgun proteomics on ovaries from pup day 17 offspring, we observed exposure effects on the proteomes. 
Nine proteins were affected in more than one exposure group and of these, we conclude that calretinin is a potential key event 
biomarker of early endocrine disruption in the ovary.
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Introduction
The foundation for a woman’s reproductive health is set dur-
ing fetal life and hinges on the development of germ cells 
and functional ovaries. The ovaries are the primary female 
sex organs responsible for the production of eggs and sex 
hormones. They are central for reproductive health through-
out adulthood, but are also involved in fetal and perinatal 
development of the female reproductive tracts and female 
sex characteristics. Disruption of ovarian development or 
function during early life stages can, therefore, have severe 
consequences later in life, affecting both fertility and health 
more broadly (Palmer et al. 2001; Hatch et al. 2006; Steiner 
et al. 2010; Hoover et al. 2011; Faubion et al. 2015).
The ovarian dysgenesis syndrome hypothesis states that 
many late-life reproductive disease manifestations arise from 
disrupted ovary development (Crain et al. 2008; Buck Louis 
et al. 2011; Johansson et al. 2017). Central to the ovarian 
dysgenesis syndrome hypothesis is that exposure to environ-
mental chemicals during fetal life is a contributing factor to 
late-life disease. A growing body of evidence indicates that 
intrauterine exposure to selected chemicals perturbs ovarian 
development and function, and possibly affects the repro-
ductive system later in life (Buck Louis et al. 2011; Johans-
son et al. 2017). There are, however, many challenges when 
linking fetal exposure to reproductive disorders in adult life. 
First, there is a significant lag time between exposure and 
disease manifestation, not least in humans. Second, the ovar-
ian dysgenesis syndrome hypothesis comprise a complex 
group of phenotypes that also vary greatly in time of onset; 
that is, they represent a complex disease pattern. Third, 
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humans are exposed to a complex, and constantly changing, 
mixture of chemicals throughout life.
Identification of the mechanisms behind later life effects 
after fetal exposure is a challenging task. Linking fetal expo-
sure to reproductive disorders in adult life require that we 
know which mechanisms were affected in the fetus during 
exposure. Omics methods have proved invaluable for identi-
fying new mechanisms and regulatory pathways within dif-
ferent fields (Frost and Amos 2018; Liu et al. 2019; Myburg 
et al. 2019). Omics approaches have also been taken up by 
the field of toxicology, as they offer new ways of integrat-
ing molecular events with health risk assessment (Brock-
meier et al. 2017; Darde et al. 2018; Filis et al. 2019). Omics 
approaches are particularly attractive for developing novel 
adverse outcome pathways (AOPs), which are conceptual 
frameworks that describe causative links between molecu-
lar events and adverse outcomes at the biological level of 
organization (Ankley et al. 2010). The combination of omics 
and the AOP conceptual framework presents an important 
approach to focus on the key molecular events in female 
reproductive disease etiology.
We have performed a proteomic analysis of rat ovaries 
collected from offspring exposed to complex mixtures of 
endocrine disrupting chemicals via their mother during fetal 
and postnatal life. These offspring displayed ovarian dys-
genesis syndrome-like symptoms when they had reached 
adulthood, with adverse outcomes including altered follicle 
numbers, abnormal mammary gland outgrowth, as well as 
advanced pubertal onset (Mandrup et al. 2015; Johansson 
et al. 2016). In aging animals, estrous cycling, number of 
corpora lutea, and mammary gland histology were adversely 
affected (Isling et al. 2014; Mandrup et al. 2015; Johansson 
et al. 2016). Thus, our aim was to identify putative molecu-
lar events that are involved in the ovarian dysgenesis syn-




Chemicals  were:  d i -n -butyl  phthala te  (DBP) 
(purity > 99.0%, CAS no. 84-74-2), di-(2-ethylhexyl) 
phthalate (DEHP) (purity > 99.5%, CAS no. 117-81-
7), vinclozolin (purity > 99.5%, CAS no. 50471-44-8), 
prochloraz (purity > 98.5%, CAS no. 67747-09-5), pro-
cymidone (purity > 99.5%, CAS no. 32809-16-8), linu-
ron (purity > 99.0%, CAS no. 330-55-2), epoxiconazole 
(purity > 99.0%, CAS no. 106325-08-8), octyl methoxycin-
namate (OMC) (purity > 98.0%, CAS no. 5466-77-3), dichlo-
rodiphenyl-dichloroethylene (p,pʹ-DDE) (purity > 98.5%, 
CAS no. 72-55-9); all purchased from VWR-Bie & 
Berntsen (Herlev, Denmark). 4-methyl-benzylidene camphor 
(4-MBC) (purity > 98.0%, CAS no. 36861-47-9), bisphenol 
A (BPA) (purity > 99.5%, CAS no. 80-05-7), butyl paraben 
(purity > 99.0%, CAS no. 94-26-8) and paracetamol (PM) 
(purity > 99.0%, CAS no. 103-90-2) were all purchased from 
Sigma-Aldrich (Brøndby, Denmark). Corn oil was used as a 
control compound and as vehicle; purchased from VWR-Bie 
& Berntsen (Herlev, Denmark).
Chemical mixtures
The composition of the mixtures was based on high-end 
human exposure levels, with the mixture designed as pre-
viously described (Christiansen et al. 2012; Axelstad et al. 
2014). In short, the Totalmix contained all 13 compounds, 
the AAmix contained compounds considered to have pre-
dominantly anti-androgenic modes of action, and the Emix 
contained compounds considered to have predominantly 
estrogenic properties (Table 1). PM was included in the 
Totalmix, as well as tested on its own, but was not included 
in the AAmix nor the Emix. The mixtures were adminis-
tered at 450-times human high-end exposure. These doses 
were predicted to affect anti-androgenic endpoints in male 
offspring (see Christiansen et al. 2012). Doses were higher 
than human exposure levels to increase the chance of regis-
tering a response from subtle effects that would otherwise 
not be detected, using a relatively small number of animals 
in a rat model with more rapid metabolism of chemicals 
than humans. PM was administered at 360 mg/kg, both in 
the Totalmix and in the single exposure, corresponding to 
human exposure levels when taking into account toxicoki-
netic differences between rats and humans (Table 1).
Table 1  Mixture composition and dose for the tested mixtures in mg/
kg per day. Design of the mixtures has previously been described 
(Axelstad et al. 2014; Christiansen et al. 2012)
Chemical Mixture dose (mg/kg per day)
Totalmix 450 AAmix 450 Emix 450 PM
DBP 4.5 4.5 0 0
DEHP 9 9 0 0
Vinclozolin 4.05 4.05 0 0
Prochloraz 6.3 6.3 0 0
Procymidone 6.75 6.75 0 0
Linuron 0.27 0.27 0 0
Epoxiconazole 4.5 4.5 0 0
p,pʹ-DDE 0.45 0.45 0 0
4-MBC 27 0 27 0
OMC 54 0 54 0
Bisphenol A 0.675 0 0.675 0
Butyl paraben 27 0 27 0
Paracetamol 360 0 0 360
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Animals and exposure
The animal study is described in (Axelstad et al. 2014). In 
short, time-mated nulliparous Wistar rats (HanTac:WH, 
SPF, Taconic Europe, Ejby, Denmark) were used and the day 
of vaginal plug detection designated GD 1, and the expected 
day of delivery (GD23) designated pup day (PD) 1. The 
dams were supplied at GD 3. Animals were exposed to vehi-
cle (controls), or one of the four mixtures (Table 1). Each 
dose group comprised 16–20 dams, and 14–20 viable litters 
were obtained for each group. Rats were exposed by oral 
gavage from GD7-21, and again after birth from PD1-22. 
Exposure to PM was from GD13-19 and PD14-22, both in 
the Totalmix and single dosing, meaning that only PM was 
given in a different time interval. This was to avoid effects on 
embryo implantation (Gupta et al. 1981) and problems dur-
ing parturition. The study was performed under conditions 
approved by the Danish Animal Experiments Inspectorate 
(Council for Animal Experimentation) and by the in-house 
Animal Welfare Committee.
Protein extraction and processing
Ovaries were collected from PD17 female offspring as these 
animals are in a period of rapid development and all stages 
of developing follicles (primordial to antral follicles) are pre-
sent. Also, in comparison to later ages, offspring is still fully 
lactating and thus receive chemicals through maternal milk. 
Ovaries were snap-frozen in liquid nitrogen, then stored at 
− 80 °C until processing. Proteins were isolated from 8 to 9 
individual ovaries per group (different litters) using the All-
Prep kit (#80004; QIAGEN, Manchester, UK) according to 
the manufacturer’s instructions. Ovaries were extracted indi-
vidually and all further analyses were conducted on individ-
ual samples. Protein concentrations were quantified using a 
modified Lowry assay (Biorad Ltd., Hertfordshire, UK, cat.
no. 500–0122). 10 μg of protein extracts were diluted to a final 
volume of 100 μl of 50 mM  NH4HCO3 (BioUltra grade, Sigma 
Aldrich). Proteins were digested in solution according to the 
PRIME-XS protocol. Briefly, proteins were reduced in 2 mM 
dithiothreitol (Sigma Aldrich, > 99%) for 25 min at 60 °C and 
S-alkylated in 4 mM iodoacetamide (Sigma Aldrich, > 99%) 
for 30 min at 25 °C in the dark, then digested by sequencing-
grade modified trypsin (Promega, Southampton, UK, cat.no. 
V5111) at a 1:10 ratio of trypsin:protein overnight at 37 °C. 
The reaction was stopped by freezing at − 80 °C. Samples were 
then thawed, dried by vacuum centrifugation (SpeedVac Plus 
SC110A, Savant) and dissolved in 10 µL 2% acetonitrile/0.1% 
formic acid. The equivalent of 2 μg of peptides (assuming no 
losses) were analysed by liquid chromatography-tandem mass 
spectrometry (LC–MS/MS). The LC–MS system comprised 
a Thermo Scientific Dionex UltiMate 3000 RSLC nano-LC 
configured for pre-concentration onto a nano column, coupled 
to a Q Exactive Plus hybrid quadrupole-Orbitrap mass spec-
trometer fitted with an EASY-Spray nano-ESI source (Thermo 
Scientific). Peptide samples were injected onto a C18 PepMap 
100 pre-column (300 µm i.d. × 5 mm) in loading pump solvent 
(2% acetonitrile, 0.1% formic acid) at a flow rate of 10 µL/min 
for 5 min. The pre-column was then reverse-flushed to the 
analytical column (PepMap RSLC C18; 50 µm i.d. × 15 cm; 
Nano pump solvent A: 0.1% formic acid, Nano pump solvent 
B: 80% acetonitrile, 0.1% formic acid) at 0.3 µL/min using 
the nano pump. Peptides were separated using a gradient of 
acetonitrile (LC gradient: 3–10% solvent B in 5 min, 10–40% 
solvent B in 30 min, 40–80% solvent B in 5 min, hold at 80% 
solvent B for 8 min, 80–3% solvent B in 1 min, hold at 3% 
solvent B for 15 min) while MS/MS data were acquired by the 
Q Exactive in data-dependent mode (Top10 method). Param-
eters for the full scan/data-dependent MS2 (Top10) method 
were: full scan range 375–1750 m/z; resolution 70,000; AGC 
target 3e6; maximum IT 50 ms. MS2 scan resolution 17,500; 
AGC target 5e4; maximum IT 100 ms; loop count 10; isola-
tion window 1.6 m/z; NCE 26; underfill ratio 4%; charge states 
2–5 included; peptide match preferred; exclude isotopes on; 
dynamic exclusion 40 s. Technical replicates for 25% of the 
samples were performed. The mass spectrometry proteomics 
data have been deposited to the ProteomeXchange Consortium 
via the PRIDE (Perez-Riverol et al. 2019) partner repository 
with the dataset identifier PXD015470.
Analysis of LC–MS/MS output
RAW Q-Exactive output files were processed in 4 runs 
(controls vs each of the four exposures) by MaxQuant (v 
1.5.3.30) (Cox and Mann 2008). MaxQuant runs were per-
formed under the default parameters except (a) trypsin was 
set as the digestion enzyme; (b) asparagine (N) deamidation 
was added in the post-translational modifications along with 
defaults methionine (M) oxidation and protein N-terminal 
acetylation; (c) protein intensities were normalized using a 
minimum ratio count of 1, no Fast LFQ, and no requirement 
for MS/MS for LFQ comparisons; (d) LC–MS/MS runs were 
matched under the default matching parameters. All searches 
were performed against a FASTA file of the Rattus norvegi-
cus (canonical and isoforms protein sequences, downloaded 
from Uniprot on 29-03-2016). Maxquant was configured to 
automatically average duplicate runs. Peptide and protein 
identifications were filtered at a 1% false discover rate (FDR) 
threshold.
RNA extraction, cDNA synthesis and quantitative 
RT‑PCR (RT‑qPCR) analysis
Gene expression analyses were conducted as previously 
described (Svingen et al. 2015). In short, total RNA was 
extracted from 9 ovaries/exposure group using the AllPrep 
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kit (#80004; QIAGEN, Manchester, UK) according to the 
manufacturer’s instructions. RNA concentrations were meas-
ured on a nanoDrop-1000 Spectrophotometer and 500 ng 
RNA/sample used for cDNA synthesis (Omniscript, Qia-
gen). RT-qPCR reaction were run in duplicates on a Quant-
Studio 7 Flex Real-Time PCR System (Applied biosystems) 
in 20 µl reactions using 3 µl diluted cDNA (1:20) as tem-
plate. TaqMan gene expression assays (Life Technologies) 
were: Calb2 (Rn00588816_m1), Ooep (Rn01746481_g1), 
Hist1h2ba (Rn00575310_s1), Snx1 (Rn01418446_m1), 
Hdhd2 (Rn01526982_m1), Eif3a (Rn01410678_m1), Hip1 
(Rn01202990_m1), Ufd1l (Rn00584715_m1), Lsm14b 
(Rn01412698_m1). Intra-assay variability was < 0.5 cycles. 
Data was analyzed by the comparative Ct-method with the 
geometric mean of the reference genes Rps18 (Rn01428913_
gH) and Sdha (Rn00590475_m1).
Statistical analysis
MaxLFQ-normalized protein intensities were handled and 
analyzed in R statistical software (v3.31). Four pairwise 
statistical comparisons (control vs each of the four expo-
sures) were performed for the proteins with normalized 
quantitative information in at least 75% of the samples in 
each comparison using the limma package in R. Statistical 
significance was defined as unadjusted P values < 0.05 that 
showed at least 1.5-fold difference. R code for the analyses 
performed is available in Online Resource 1. All identified 
proteins and peptides, including fold differences, unadjusted 
and adjusted P values for all four exposures are provided in 
Online Resource 2. qPCR data was analyzed by ANOVA and 
Dunnett’s post-hoc test in the software GraphPad Prism 8. 
Where data was not normally distributed among all groups, 
a log transformation was applied.
Pathway mapping
Ingenuity Pathway Analysis (IPA) V9.0 (Ingenuity Systems, 
https ://www.ingen uity.com) was used to assign affected pro-
teins Disease and Functions pathways (Bellingham et al. 
2013; Filis et al. 2015) and to map likely upstream regula-
tors using the differentially expressed proteins as inputs. Pre-
dicted disease and functions pathways are shown in Table 2 
and upstream regulators in Table 3.
Results
Chemical mixture‑specific alteration of the ovarian 
proteome
After quality filtering there were 2561 distinct proteins in 
the AAmix group, 2463 in the Emix group, 2462 in the 
PM group, and 2333 in the Totalmix group. The Totalmix 
resulted in the highest number of putatively dysregulated 
proteins in the ovaries (106 proteins), whereas AAmix 
resulted in 19 proteins with altered expression, the Emix 
in 12 altered proteins, and Paracetamol 11 altered proteins 
(Fig. 1a).
Proteins that were changed in Totalmix-exposed ovaries 
included transcription factors (MED25, NFIC, FOXP4, 
LOM4, STAT6, and NFIX), proteins involved in the post-
transcriptional processing of RNA (TFIP11, DHX57, 
SKIV2L, THOC6, CMTRL, PCIFL, AQR, ENY2, and 
DDX39A), cytoskeletal-organization (LCP1, CORO1A, 
NUDCD3, MAP1B, and STMN1), and proteins associated 
with intracellular trafficking (GGA1, KIF13A, RAB3GAP2, 
SNX29, MAPKAPK2, SEC24C, and SNX1). There was also 
increased expression of CES1, a detoxifying enzyme, and 
HSD17B12, a key enzyme in ovarian estradiol production. 
These, and the remainder of proteins displaying altered rela-
tive expression, are listed in Online Resource 2.
Proteins that were changed in the AAmix-exposed ovaries 
included the nuclear transport proteins NUP88 and KPNA1, 
cytoskeletal organization proteins (SYNPO2, S100A11, 
MSN and KRT31), and protein involved in metabolism 
(EIF1B, RBX1, and NPEPL1) (Online Resource 2). In 
Emix-exposed ovaries, the expression of proteins involved 
in translation (LSM14B, EIF3A) and signal transduction 
(ANPEP, LANCL1 and INPPL1) were changed, whereas 
the proteome of PM-exposed ovaries displayed upregula-
tion of the immunoglobulin lambda chain (LAC) and the 
pro-apoptotic protein CASP3, as well as changes to expres-
sion of the endocytosis factors HIP1 and ANKFY1 (Online 
Resource 2).
Common proteins in chemical mixture induced 
alteration of the ovarian proteome
Proteins that were altered in more than one exposure group 
were affected in the same direction; i.e. upregulated or 
downregulated (Fig. 1b, Online Resource 2). CALB2, 
SNX1, HIST1H2BA and OOEP were similarly affected 
in both AAmix and Totalmix with CALB2 expression 
being reduced 12-fold by Totalmix and fourfold by AAmix 
(Fig. 1b, Online Resource 2). LSM14B and UFD1L were 
upregulated after exposure to both Emix and Totalmix 
whereas HDHD2 was upregulated by exposure to Emix, 
PM or Totalmix (Fig. 1b, Online Resource 2). AAmix 
exposed ovaries only showed proteins with altered expres-
sion levels in common with Totalmix and not with the 
other two exposure groups (Fig. 1b). For the nine pro-
teins that were changed in more than one exposure group 
(Fig. 1b) we chose to investigate gene expression levels. 
For Calb2, a downregulation similar to the one seen at 
proteome level (12.5 fold downregulation in Totalmix 
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and 4.3 fold downregulation in AAmix) was also found 
at gene expression level (P = 0.03 in Totalmix, P = 0.003 
in AAmix, Fig. 2a). For the remaining eight proteins, a 
fold change between 1.6 and 2.4 was seen in the proteome 
analysis. These changes were not mirrored at the transcript 
level (Fig. 2b–i).
Pathway analyses of the affected proteins
Changes to the proteome caused by Totalmix were predica-
tive of increased cancer risk, cell orientation and leucocyte 
migratory functions in the ovary (Table 2). Totalmix was 
also predicted to activate pathways relating to infection 
Table 2  Disease and function predicted by ingenuity pathway analysis
Categories Annotation P value Z score Exposure
Cell death and survival DNA fragmentation 0.016 − 0.85 Totalmix
Cellular assembly and organization Formation of cytoskeleton 0.014 − 0.82 Totalmix
Cellular assembly and organization Formation of filaments 0.018 − 0.82 Totalmix
Cellular assembly and organization Stabilization of microtubules 0.002 − 0.76 Totalmix
Molecular transport Transport of molecule 0.001 − 0.59 Totalmix
Cellular assembly and organization Development of cytoplasm 0.015 − 0.28 Totalmix
Protein synthesis Catabolism of protein 0.017 0.45 Totalmix
Protein synthesis Metabolism of protein 0.015 0.82 Totalmix
Cellular movement Cell movement of mononuclear leukocytes 0.038 1.05 Totalmix
Carbohydrate metabolism Glycolysis 0.001 1.07 Totalmix
Lipid metabolism Concentration of lipid 0.027 1.12 Totalmix
Gene expression RNA transactivation 0.003 1.17 Totalmix
Cell-to-cell signaling and interaction Adhesion of immune cells 0.025 1.43 Totalmix
Cellular function and maintenance Internalization of cells 0.014 1.43 Totalmix
Cellular movement Chemotaxis of leukocytes 0.029 1.67 Totalmix
Cell-to-cell signaling and interaction Binding of blood cells 0.021 1.70 Totalmix
Cell morphology Polarization of cells 0.005 1.95 Totalmix
Infectious diseases Replication of RNA virus 0.006 1.96 Totalmix
Cellular movement Migration of myeloid cells 0.005 1.98 Totalmix
Cellular movement Migration of granulocytes 0.010 1.98 Totalmix
Cell morphology Orientation of cells 0.001 2.18 Totalmix
Cancer Metastasis of cells 0.025 2.20 Totalmix
Infectious diseases Replication of Influenza A virus 0.030 2.21 Totalmix
Cell death and survival Apoptosis 0.041 0.40 Emix
Cell death and survival Necrosis 0.012 1.09 Emix
Cellular assembly and organization Microtubule dynamics 0.029 1.41 Emix
Cell-to-cell signaling and interaction Activation of cells 0.004 − 1.98 PM
Table 3  Mapping of upstream 
regulators by ingenuity pathway 
analysis
Upstream regulator Type P value Z score Exposure
l-Triiodothyronine Endogenous hormone 0.036 − 1.206 Totalmix
Phosphatase and tensin homolog (Pten) Phosphatase 0.029 − 1.067 Totalmix
Homebox protein Hox-A10 (Hoxa10) Transcription regulator 0.013 − 1.000 Totalmix
Progesterone Endogenous hormone 0.031 − 0.816 Totalmix
Estrogen receptor Nuclear receptor 0.033 1.000 Totalmix
Matrix metalloproteinase-3 (Mmp3) Proteinase 0.002 1.000 Totalmix
Vitamin D3 Endogenous chemical 0.002 1.342 Totalmix
Retinoic acid Endogenous chemical 0.517 1.948 Totalmix
Genistein Phytoestrogen 0.051 2.177 Totalmix
Interleukin 13 (IL13) Cytokine 0.044 2.207 Totalmix
Estradiol Endogenous hormone 0.001 − 0.152 PM
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(replication of RNA viruses), RNA transactivation, and 
to increase lipid concentration. Changes to the proteome 
in the Emix group mapped to increase in microtubule 
dynamics and increased necrosis whereas the paracetamol 
treatment changes predicted decreased cellular activation 
(Table 2). Mapping of upstream regulators likely to explain 
the observed changes to the proteome suggested increased 
IL13, retinoic acid, Vitamin D3, Matrix Metalloproteinase 3 
(Mmp3) and estrogen receptor signaling, whereas it reduced 
l-triiodothyronine (T3) (Table 3). Downregulated activity 
for the transcription factor Hoxa10 and of the phosphatase 
Pten was also predicted after exposure to Totalmix (Table 3).
Fig. 1  Summary of proteomic findings: a Proteome differences 
between control and Totalmix, AAmix, Emix and PM. For Totalmix 
2333 proteins were compared and 16 proteins were upregulated and 
90 proteins downregulated. For AAmix 2561 proteins were com-
pared and 7 proteins were upregulated and 12 proteins downregu-
lated. For Emix, 2463 proteins were compared and 9 proteins were 
upregulated and 3 proteins downregulated. For PM 2462 proteins 
were compared and 5 proteins were upregulated and 6 proteins down 
regulated. b Venn diagram showing affected proteins overlapping 
between exposure groups. Totalmix had two upregulated proteins in 
common with Emix [Protein Lsm14b (LSM14B), Ubiquitin fusion 
degradation protein 1 homolog (UFD1L)], four proteins in common 
with AAmix where two were downregulated [Calretinin (CALB2), 
Sorting nexin-1 (SNX1)] and two upregulated [Histone H2B type 1-A 
(HIST1H2BA), Protein Ooep (OOEP)]. Totalmix also had one pro-
tein in common with both Emix and PM [haloacid dehalogenase-like 
hydrolase domain-containing protein 2 (HDHD2)]. Emix and PM had 
two upregulated proteins in common [Huntingtin interacting protein 1 
(HIP1), Eukaryotic translation initiation factor 3 subunit A (EIF3A)]. 
AAmix and PM had no protein overlap (Totalmix: DBP, DEHP, vin-
clozolin, prochloraz, procymidone, linuron, epoxiconazole, p,pʹ-DDE, 
4-MBC, OMC, BPA, Butyl paraben, paracetamol; AAmix: DBP, 
DEHP, vinclozolin, prochloraz, procymidone, linuron, epoxiconazole, 
p,pʹ-DDE; Emix: OMC, BPA, Butyl paraben; PM: paracetamol)
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Discussion
Exposure to endocrine disrupting chemicals are likely a 
contributing factor to ovarian dysgenesis syndrome since 
many chemicals can interfere with both germ cell develop-
ment and sex hormone synthesis and action (Buck Louis 
et al. 2011; Johansson et al. 2017). However, because of the 
multifaceted disease pattern and the fact that humans are 
exposed to complex mixtures of chemicals, it is challenging 
to establish cause-effect relationships and to pinpoint the 
specific molecular events occurring in the young individual 
that is responsible for the effects seen in the adult. Here we 
report new knowledge of ovarian molecular pathways, at the 
level of the proteome, that may be disrupted and responsible 
for female reproductive disorder and which will contribute 
to much-needed AOP development.
To discover mechanisms that would cover a broad range 
of female reproductive disease manifestations arising from 
Fig. 2  Gene expression analysis 
for the nine proteins that were 
dysregulated in more than one 
exposure group. a Calb2 tran-
script expression was signifi-
cantly downregulated following 
exposure to Totalmix (P = 0.03) 
or AAmix (P = 0.003). b–i No 
significant effects on expression 
levels of the remaining 8 genes 
encoding proteins that were 
dysregulated in more than one 
exposure group were seen (data 
is presented as mean ± SEM, 
*P < 0.05, **P < 0.01, n = 9/
exposure group)
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exposure to real-life chemical mixtures, we performed shot-
gun proteomic analyses on rat ovaries obtained from juve-
nile offspring exposed to four different chemical mixtures 
comprising known EDCs during fetal and postnatal life. 
By doing so, we could investigate effects on thousands of 
proteins after exposure to complex chemical mixtures more 
resembling human exposure patterns than what is the case 
for single chemical exposures. We found several differen-
tially expressed proteins across the four exposure groups, 
with nine proteins being altered in more than one exposure 
group (CALB2, SNX1, HIST1H2BA, OOEP, LSM14B, 
UFD1L, HDHD2, HIP1, EIF3A). This is promising in view 
of detecting a molecular initiating event or key event that 
can potentially serve as a reference point for a wide range of 
chemicals. As expected, some of the proteins altered in the 
Totalmix group were also altered in other exposure groups. 
Also, the Emix and PM groups showed proteins with altered 
expression in common with each other, whereas AAmix only 
had misexpressed proteins in common with Totalmix, sepa-
rating this group from Emix and PM. This is of particular 
interest as Totalmix and AAmix showed marked long-term 
effects on the ovary in a previous study (Johansson et al. 
2016). Of the various proteins, calretinin (CALB2) displayed 
greatest change in relative expression level, and the effect 
was replicated at the transcript level.
Calretinin is a calcium binding protein that buffers 
the  Ca2+ levels in the cell (Schwaller 2014). Calretinin 
was first identified in the nervous system (Rogers 1987; 
Andressen et al. 1993) and most research into its function 
has been carried out on brain tissues (Schwaller 2014). 
However, calretinin is also expressed in non-excitable 
cells in several other tissues, including the ovary where 
it is expressed in the theca interna of follicles and theca 
lutein cells in corpora lutea (Bertschy et al. 1998; Lugli 
et al. 2003). In relation to the female reproductive system, 
calretinin is best known as a diagnostic marker for sev-
eral types of gynecological tumors, where it is ectopically 
activated (Portugal and Oliva 2009). In the present study, 
calretinin was downregulated in ovaries after exposure to 
mixtures containing anti-androgenic chemicals (Total-
mix and AAmix). Since the theca cells are the androgen 
producing cells of the ovary, and the cells that express 
calretinin (Bertschy et al. 1998; Lugli et al. 2003), there 
may be two explanations for the downregulation of cal-
retinin following chemical exposure. One, theca cell dif-
ferentiation or maintenance may be affected so that their 
overall numbers are reduced; in other words, intracellular 
calretinin is not affected but there are fewer cells in the 
ovary expressing calretinin. Two, calretinin expression is 
directly affected, indicating compromised theca cell func-
tion. In the fetal testis, calretinin levels are correlated with 
the number of Leydig cells (Altobelli et al. 2017). Since 
ovarian theca cells corresponds to testicular Leydig cells, 
at least in terms of androgen production, similar functions 
for calretinin in the ovary are likely, which would lend 
support to the first scenario where it is the theca cell num-
bers that are affected.
Also, recent findings suggest that calretinin is involved 
in Leydig cell function by protecting against cell apopto-
sis (Xu et al. 2017) and by promoting steroidogenesis (Xu 
et al. 2018). Thus, the potential importance of calretinin in 
androgen producing cells, as well as the effects on primor-
dial follicles and reproductive senescence seen in littermates 
exposed to anti-androgenic mixtures (Johansson et al. 2016), 
indicates that calretinin could be a potential marker not only 
of anti-androgenic effect, but potentially also for late life 
ovarian dysgenesis.
Mapping of upstream regulators showed interesting 
results with regulation through molecules such as retinoic 
acid, phosphatase and tensin homolog, and vitamin D3. 
Whether or not any of these proteins are actually molecular 
initiating events or key events remains unanswered, but they 
could serve as starting points for further investigations. As 
an example, retinoic acid plays a central role in germ cell 
development and particularly meiotic initiation (Koubova 
et al. 2006; Bowles et al. 2006).
The ovary is a dynamic organ undergoing dramatic 
changes during the menstrual/estrous cycle in adult indi-
viduals and also during pre-pubertal development (Picut 
et al. 2015). This, coupled with the fact that many changes 
to the ovaries caused by chemical exposure likely would 
have occurred early in life (Johansson et al. 2017), makes 
it difficult to catch causative changes to protein expression. 
Thus, timing is a critical factor in the search for molecular 
initiating, or key events, especially when also considering 
that the ovary is a heterogeneous tissue. Omics approaches 
are good avenues for searching for such mechanisms, but 
they also have their drawbacks. With regard to shotgun pro-
teomics, it must be noted that only the most abundant pro-
teins are detected (Cayer et al. 2016), and not necessarily 
those with the biggest changes in expression levels or that 
are functionally relevant for the diseases in question. In this 
study, we have allowed for less stringent adjusted p-value 
cut offs, a practice not uncommon when dealing with in vivo 
proteomic data sets (Pascovici et al. 2016), and to reflect 
biological relevance and to mitigate Type 1 statistical errors 
we have used fold difference cut offs. Our reported list of 
affected proteins may therefore contain false-positives, but 
at the same time it likely contains important protein mark-
ers that describe mechanisms of ovarian dysgenesis. The 
nine proteins we chose for further investigation may be an 
excellent example of this. We found effects on transcrip-
tional regulation of Calb2 (calretinin), whereas we did not 
see any effects on Ooep, Hist1h2ba, Snx1, Hdhd2, Eif3a, 
Hip1, Ufd1l, Lsm14b. This could indicate that these eight 
proteins are regulated at post-transcriptional level, or that 
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they represent false positives. Regardless, rigorous follow-
up studies on the reported protein targets is required to pass 
judgment on their bona fide involvement in disease causation 
or development.
Overall, our study has highlighted calretinin as a poten-
tially interesting target for many of the female disorders 
that fall under the ovarian dysgenesis syndrome umbrella. 
Since we observed a significant downregulation of calretinin 
both at the protein and transcript level, we conclude that 
calretinin is a strong candidate for a key event in ovarian 
dysgenesis syndrome. Downregulation of calretinin was 
seen in the Totalmix and AAmix groups, indicating that 
altered expression of calretinin is a direct consequence of 
anti-androgenic effects. This data warrants further studies of 
calretinin’s role in signaling pathways in the developing as 
well as the adult ovary, directed towards much-need ovarian 
AOP development.
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